Tianxing Medical, a sports medicine equipment company based in Beijing, is planning to go public in Hong Kong. Quite interesting. They have 52 types of products, covering implants, devices, consumables, and so on. It appears to be a comprehensive solution provider.



The performance is quite good. Last year's revenue was 327 million, with a profit of 95 million. The gross profit margin is around 70%, which is quite high. The overseas business has grown particularly rapidly, increasing by 370% in the first five months of this year. Its share jumped from 6.4% to 18.4%, which is a significant increase.

However, there are also some issues. The income structure is single, with implants accounting for more than 70%. Group purchasing may drive down prices. Additionally, the actual controller has changed, and some people are not very reassured.

Overall, Tianxing Medical Technology is good, and its overseas business is growing rapidly. The sports medicine market has great potential. Whether it can go public is something everyone is watching.

When it comes to sales volume, it refers to how much is sold. It is very important for businesses. For forecasting, historical data can be multiplied by the growth rate. Excel has the FORECAST function, and SQL can use linear regression or moving averages. How to choose specifically depends on the situation.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)